Last deal

$15M

Amount

Post-IPO Equity

Stage

27.08.2013

Date

3

all rounds

$86.9M

Total amount

date founded

Financing round

General

About Company
WaferGen Biosystems offers genomic tools for targeted resequencing, genotyping, and expression analysis.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2002

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Their SmartChip Real-Time PCR System is a next-generation platform for profiling and validating molecular biomarkers, while the ICELL8 Single-Cell System is a revolutionary platform for isolating thousands of single cells for various analysis methods. These technologies offer powerful tools for biological analysis at the molecular and single-cell levels in the life sciences, pharmaceutical, and clinical laboratory industries.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Affymetrix

Affymetrix

Faymetrix provides innovative technologies for multiplex and parallel analysis of biological systems.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Santa Clara, CA, USA
Mission Bio

Mission Bio

Mission Bio is a precision genomics company that develops a single-cell multi-omics platform for cancer research and biomarker development.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Genetics

Location

San Francisco, CA, USA

total rounds

11

total raised

$150.9M
Wancheng Gene

Wancheng Gene

Wancheng Gene is a single-cell gene detection platform serving scientific, clinical, and industrial markets.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Shanghai, China

total rounds

2

total raised

$16.44M
Swift Biosciences

Swift Biosciences

Swift Biosciences develops and commercializes NGS Library Preparation Kits that expand the applications of next-generation sequencing.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Ann Arbor, MI, USA

total rounds

7

total raised

$31.2M
M&A Details
1

Transaction name

Acquired by

Takara Bio

announced date

13.05.2016

price

$50M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$86.9M

Money Raised

Their latest funding was raised on 27.08.2013. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
27.08.2013
$15M
01.06.2012
$30.55M
31.05.2011
3
$30M
Co-Investors
Investors
3
0

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
No
Post-IPO Equity
No
Post-IPO Equity
No
Post-IPO Equity
Deerfield

Deerfield

Deerfield is an investment management firm that specializes in healthcare investments, including information, investment, and philanthropy.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

total rounds

1

total raised

$25M

count Of Investments

193

count Of Exists

36
Great Point Partners

Great Point Partners

Great Point Partners invests in biotech, pharma, medtech, and healthcare service companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Health Care, Advice

Location

Greenwich, CT, USA

count Of Investments

49

count Of Exists

15
Merlin Nexus

Merlin Nexus

Merlin Nexus is an investment management company focused on crossover private equity investing in the life sciences industry.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

count Of Investments

7

count Of Exists

3

People

Founders
1

Victor Joseph

current job

WaferGen Biosystems
WaferGen Biosystems

organization founded

1

Victor Joseph

Employee Profiles
5

Jude Dunne

Vice President

John Harland

CFO

Victor Joseph

Founder

Activity

Recent News
0